Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| St. Olavs Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
There is an urgent need to implement novel diet approaches to combat the increasing rates of gestational diabetes mellitus (GDM). The primary aim of this study is to establish the feasibility of time-restricted eating in pregnancy, to prepare for future larger controlled trials in this research project to determine the efficacy of time-restricted eating in women at risk of GDM. Expectations:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Time restricted eating (TRE) | Experimental | prolonging the duration of fasting between the last evening meal and the first meal of the next day |
|
| control | No Intervention | Standard care. Will receive a booklet about physical activity recommendations and healthy eating in pregnancy |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| time restricted eating (TRE) | Behavioral | Participants will attend a face-to-face meeting with the researchers at the last day of the first week of data collection (habitual diet and physical activity period) where they will be counselled to consume all food and fluid within a 8-10 h time window of their choice starting no later than 09.00 h for five weeks. During the intervention period, they will be counselled by weekly phone calls to provide encouragement, support and monitoring to improve adherence to the TRE window. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in average time-window for energy intake | Average daily time-window for energy intake will be registered through log books. | Change between baseline (pre-intervention) time-window for energy intake to average time-window for energy intake during the 5-week intervention period |
| Weekly adherence rates for time restricted eating (TRE) | The number of days per week that the participants are able to adhere to TRE, as calculated as weekly average of days with a time-window ≤ 10 hours | Weekly measures throughout the 5 week period of TRE intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Perceived barriers to the protocol assessed with an unstructured interview | Participants will be asked about which barriers they perceived as challenging regarding keeping to a TRE schedule and if they have strategies to overcome these barriers. | Weekly phone calls to participants in TRE group during the 5-week intervention period and after 6 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Øystein Risa, phd | Department of circulation and medical imaging, NTNU | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Olavs Hospital | Trondheim | Norway |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Subjective appetite sensations assessed by Visual Analogue Scales | Paper line scales 100 mm on scales for Hunger ("How hungry are you": From "Not at all" = 0 on the scale to "Extremely. As hungry as I have ever felt" =100 on the scale, Fullness (From "Not at all" = 0 on the scale to "Extremely. As full as I have ever felt" = 100 on the scale, Satiety ("How satiated are you" From "Not at all" =0 on the scale to "Extremely" =100 on the scale, Desire to eat ("How strong is your desire to eat" From "Very weak. Extremely low" = 0 on the scale to "Very strong. Extremely high" = 100 on the scale and Prospective consumption (quantity) ("How much do you think you could (or would want to) eat right now?" From "Nothing at all" = 0 on the scale to "A very large amount" = 100 on the scale. Scales will be filled in in the morning, before dinner and at bedtime. | Once weekly throughout 6 weeks, on a weekday. |
| Change between baseline and post-intervention in fasting glucose | Post-intervention fasting glucose minus pre-intervention fasting glucose | 6 weeks |
| Change between baseline and post-intervention in postprandial glucose | Blood glucose levels 120 minutes after ingestion of 75 g glucose (oral glucose tolerance test) | 6 weeks |
| Change between baseline and post-intervention in fasting insulin | Circulating insulin levels | 6 weeks |
| Change between baseline and post-intervention in postprandial insulin | Circulating insulin levels 120 minutes after ingestion of 75 g glucose. | 6 weeks |
| Change between baseline and post-intervention blood pressure | Diastolic and systolic blood pressure | 6 weeks |
| Change between baseline and post-intervention body mass | Body mass in kg. | 6 weeks |
| Change in total cholesterol | Total cholesterol measured in blood | 6 weeks |
| Change in triglycerides | Triglycerides measured in blood | 6 weeks |
| Change in HDL cholesterol | HDL cholesterol measured in blood | 6 weeks |
| Change in LDL cholesterol | LDL cholesterol measured in blood | 6 weeks |
| Change in HbA1c | HbA1c measured in blood | 6 weeks |
| Continuous glucose monitoring | Interstitial glucose measurements | 6 weeks |
| Change between baseline and post-intervention fat mass | Fat mass in kg and percent of body mass | 6 weeks |
| Change between baseline and post-intervention muscle mass | Muscle mass in kg | 6 weeks |
| Change between baseline and post-intervention visceral fat area | Visceral fat area in squared cm. | 6 weeks |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |